Bibliographic details
Thanh NX, Chuck AW, Ohinmaa A, Jacobs P. Benefits of pharmaceutical innovation: the case of simvastatin in Canada. International Journal of Technology Assessment in Health Care 2012; 28(4): 390-397
MeSH
Adolescent; Adult; Anticholesteremic Agents /therapeutic use; Canada; Coronary Artery Disease /drug therapy /economics /mortality; Diffusion of Innovation; Drug Industry /economics; Female; Health Care Costs; Humans; Male; Middle Aged; Public Health /economics; Simvastatin /therapeutic use; Survival Analysis; Young Adult